The company has announced plans to introduce comprehensive at-home lab tests, leveraging the acquisition of Trybe Labs, which could enhance service personalization and attract new customers. Additionally, expansion into markets such as Canada and Europe (through the acquisition of Zava) opens new revenue growth opportunities. The company demonstrates continuous financial improvement, including record profitability and a 111% revenue increase since reaching its ATH (All-Time High) in February 2025, which builds investor confidence.
The chart analysis of Hims & Hers Health, Inc. (NYSE: HIMS) indicates a clear upward trend in the recent period. The current price is approximately 49.38 USD. Based on historical data and visible momentum, there is potential for a growth of about 50%, which could bring the price to around 75 USD. Key support is located around 45 USD, while resistance may be tested in the 55-60 USD range before further upward movement. It is recommended to monitor volume and key technical levels to confirm the continuation of the trend.
Potential TP: 75 $
The chart analysis of Hims & Hers Health, Inc. (NYSE: HIMS) indicates a clear upward trend in the recent period. The current price is approximately 49.38 USD. Based on historical data and visible momentum, there is potential for a growth of about 50%, which could bring the price to around 75 USD. Key support is located around 45 USD, while resistance may be tested in the 55-60 USD range before further upward movement. It is recommended to monitor volume and key technical levels to confirm the continuation of the trend.
Potential TP: 75 $
トレード稼働中
Target done!
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。